Muhammad B. Yunus

Muhammad B. Yunus

Auto-generated profile, based on publicly available information

Muhammad B. Yunus

Department of Medicine, University of Illinois College of Medicine, Peoria 61656

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

2 July 2015 in Current Rheumatology Reviews
Verified
Journal Article
Closed access
MYMuhammad Yunus
Muhammad Yunus
Central sensitization (CS), simply defined as an amplified response of the central nervous system to peripheral input, is a concept of great importance in clinical medicine. It has helped to explain aspects of the pathophysiology of common diseases, e.g. fibromyalgia syndrome (FMS), irritable bowel syndrome, vulvodynia, headaches, chronic pelvic pain and other overlapping conditions (collectively called central sensitivity syndromes, or CSS). It also applies to pain of complex regional pain syndrome, osteoarthritis (OA), rheumatoid arthritis (RA) and post-operative pain. The pathology-pain gap in CSS is readily explained by CS. Many FMS and other CSS patients have peripheral pathology, e.g. nociceptive areas in the muscles, arthritis, small fiber neuropathy and inflammation. Pro-inflammatory cytokines are elevated in some patients. Identification of CS in patients with structural pathology, e.g. OA and RA, has helped to explain why not all patients benefit from nonsteroidal anti-inflammatory drugs or joint replacement surgery, and require therapy directed at CS. Glial cells are important in pain processing. Remarkable advances have been achieved in neuroimaging, including visualization of grey matter and white matter, not only during provoked pain but also pain at rest. Based on CS mechanisms, targeted individual therapy may now be possible. Appropriate nosology is important particularly for effective patient care. Dichotomy of neurochemical-structural (“functional”) and structural (“organic”) pathology should be abandoned; many patients have both. Psychobiology is also biology. Patient-blaming terms like somatization, somatizer and catastrophizing should be avoided. For therapy, both pharmacological and non- pharmacological approaches are important, including recognition of subgroups and person/patient-centered care.

1 June 2007 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
MYMuhammad B. Yunus
Muhammad B. Yunus

1 March 2001 in Current Rheumatology Reports
Verified
Journal Article
Closed access
PDF file
MYMuhammad B. Yunus
Muhammad B. Yunus

1 January 2002 in Scandinavian Journal of Rheumatology
Verified
Journal Article
Closed access
MYMuhammad B. Yunus
Muhammad B. Yunus
SASule Arslan
Sule Arslan
JAJean C. Aldag
Jean C. Aldag
Objective: to evaluate the relationship between body mass index (BMI) and features of the fibromyalgia syndrome (FMS). Methods: 211 female patients with FMS seen consecutively in our rheumatology clinic were analyzed. Spearman correlation was used. Further, FMS features were compared at different levels of BMI (kg/m 2 ), e.g., < 25.00 vs S 25.00 (normal vs overweight). P value of h 0.01 was accepted as significant. Results: A significant positive correlation was found between BMI and age (p < 0.001) and a negative correlation between BMI and education (p < 0.009). Health Assessment Questionnaire (HAQ) score was significantly correlated with BMI (p < 0.001), whereas fatigue and number of tender points (TP) showed a trend (p = 0.035 and 0.037, respectively). Conclusion: The HAQ score is significantly associated with BMI in FMS with a trend towards significance for fatigue and TP. Weight loss may improve physical functioning in this disorder.

1 October 2004 in Current Pain and Headache Reports
Verified
Journal Article
Closed access
PDF file
FIFatma Inanici
Fatma Inanici
MYMuhammad B. Yunus
Muhammad B. Yunus